DNA nanomaterials offer promising advancements in addressing the challenges of rheumatoid arthritis (RA) through targeted drug delivery, biomarker detection, and therapeutic innovation.
Bibliometric analysis of the application of inorganic nanomaterials to autoimmune diseases is used to characterize current research trends and to visualize past and emerging trends in this field in the past 15 years.
CD24-PfFn-SIN targets RA joints via CD24–Siglec-10/DAMP interactions, enhancing selectivity, reducing inflammation, and repairing cartilage/bone damage. The graphical abstract was created in BioRender. Gao, O. (2025) https://BioRender.com/rf0c0hr.
Rheumatoid arthritis (RA) is a systemic, chronic autoimmune disease.
The therapeutic potential of genistein (GEN) in rheumatoid arthritis (RA), particularly with regard to its role in exosome secretion and the inflammatory microenvironment through the Rab27/Mfge8/nSMase2 pathway.